Now, after rumors saying Cupertino wants to charge extra for this device, Sisa Journal believes this iPhone will be a replacement for the Plus model, and Apple will likely keep the exact price ...
Evercore ISI analyst Vijay Kumar raised the firm’s price target on Exact Sciences (EXAS) to $70 from $60 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for ...
Any in your portfolio? Citigroup raises price target on ULTA and SNAP. Centers for Medicare & Medicaid Services finalizes 2025 pricing for Exact Sciences' Cologuard Plus, raising Medicare ...